Patent · US Active

Antibodies against cancer antigen TMEFF2 and uses thereof

US8257708B2 · kind B2 · utility

0Cited by

3References

21Claims

0Family size

Assignee

Abbott Biotherapeutics Corp. · US

Inventors

Vinay Bhaskar · South San Francisco, US
Agustin de la Calle · Planegg, DE
Debbie Law · San Francisco, US
Ingrid Caras · San Francisco, US
Vanitha Ramakrishnan · Belmont, US
Richard Murray · Pasadena, US
Daniel Afar · Santa Monica, US
David Powers · Fairfax, US

Key dates

Filing date	Sep 28, 2010
Grant date	Sep 4, 2012
Priority date	—
Expiry date	Sep 28, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/77
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the identification and generation of antibodies that bind to TMEFF2 proteins which are involved in cancer. Further, the invention provides for the use of these antibodies in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.